Outcomes of reverse shoulder arthroplasty in small- and large-stature patients.
As the worldwide use of reverse shoulder arthroplasty (RSA) increases, a range of implant sizes may be required to match regional and ethnic variation in patients' stature. Size-mismatched implants may possibly result in poorer surgical outcomes. The purpose of this study was to compare the outcomes of primary RSA in patients at the extreme ends of the growth curve with those in average-stature patients in the United States. A multicenter shoulder arthroplasty database was retrospectively reviewed to identify all primary RSAs using a single implant system with a minimum 2-year follow-up. Small patients were defined as the height of <155 cm, tall as >183 cm, and average as 162-178 cm. Active range of motion (ROM), visual analog scale pain score, and patient-reported outcomes (PROs) were compared among the 3 groups. The study included 552 shoulders (130 small, 384 average, and 38 tall stature). Preoperatively, the average height group had significantly less ROM than the other groups, but there were no significant differences in postoperative ROM. This resulted in poorer improvements in postoperative ROM in the small and tall groups, with the small-stature patients having significantly less ROM improvement compared with average-stature patients. However, these differences did not result in poorer PROs between groups. Small- and large-stature patients showed inferior improvements in ROM after RSA compared with average-stature patients. Our results suggest that current implants optimize ROM gains for average-stature patients and improve PROs independently of patient stature at a minimum 2-year follow-up.